Volume 27, Number 3—March 2021
Synopsis
Decentralized Care for Rifampin-Resistant Tuberculosis, Western Cape, South Africa
Table 3
Linear temporal trends in magnitude and duration of movement for adult patients with RR TB, Western Cape, South Africa, 2012–2014*
Description | Overall, n = 2,878 |
Cape Town, n = 1,878 |
Outside Cape Town, n = 1,000 |
Interaction p value† | |||||
---|---|---|---|---|---|---|---|---|---|
Slope (95% CI) | p value | Slope (95% CI) | p value | Slope (95% CI) | p value | ||||
Hospitalization in TB hospital, no. (%)
No. patients with >1 sample from a specialized TB hospital in the first year after RR TB diagnosis |
−0.4
(−1.2 to 0.5) |
0.33 |
−1.0
(−1.7 to −0.2) |
0.02 |
1.1
(−0.9 to 3.1) |
0.23 |
0.03 |
||
Moved to care outside TB hospital, no. (%)
No. patients with a sample from a TB hospital who had a subsequent sample from a non-TB hospital <3 mo after the most recent sample in the TB hospital |
0.2
(−0.9 to 1.3) |
0.69 |
0.1
(−1.3 to 1.6) |
0.84 |
−0.01
(−1.8 to 1.8) |
0.99 |
0.89 |
||
Median length of TB hospital stay, d (IQR)
Median hospitalization period of patients who moved to care outside of a TB hospital in the first year after RR TB diagnosis |
−1.5
(−5.7 to 2.6) |
0.42 |
−3.6 (−8.7 to 1.5) |
0.14 |
−0.28
(−4.3 to 3.7) |
0.87 |
0.24 |
||
Any movement, no. (%)
No. patients who had samples from >2 different facilities in first year after RR TB diagnosis |
−0.5
(−1.2 to 0.3) |
0.19 |
−0.9
(−1.7 to −0.06) |
0.04 |
0.5
(−1.2 to 2.3) |
0.50 |
0.10 |
||
Median no. of visits (IQR)
No. unique days with >1 laboratory sample in the first year after RR TB diagnosis |
0.04
(−0.01 to 0.1) |
0.12 |
0.0
(−0.2 to 0.2) |
>0.99 |
0.1
(−0.01 to 0.2) |
0.06 |
0.22 |
||
Median total distance, km (IQR)
Total Euclidian distance between all facilities visited by each patient in the first year after RR TB diagnosis |
−0.1
(−0.4 to 0.2) |
0.43 |
−0.3
(−0.5 to −0.01) |
0.04 |
4.7
(−1.3 to 10.6) |
0.10 |
0.07 |
||
Median distance between consecutive visits, km (IQR) Median distance between facilities visited consecutively by each patient in the first year after RR TB diagnosis | −0.06 (−0.2 to 0.04) | 0.21 | −0.18 (−0.4 to −0.02) | 0.07 | 2.5 (−0.5 to 5.6) | 0.09 | 0.05 |
*Patients without second-line drug resistance who attended >2 visits. Estimates are change per quarter (i.e., 3 mos). RR, rifampin-resistant; TB, tuberculosis. †p value of interaction term between quarter of diagnosis and location.